GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (OTCPK:SGIOY) » Definitions » Net Income Including Noncontrolling Interests

Shionogi (Shionogi) Net Income Including Noncontrolling Interests : $1,103 Mil (TTM As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Shionogi Net Income Including Noncontrolling Interests?

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Shionogi's Net Income Including Noncontrolling Interests for the three months ended in Mar. 2024 was $228 Mil. Its Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 was $1,103 Mil.

Shionogi Net Income Including Noncontrolling Interests Historical Data

The historical data trend for Shionogi's Net Income Including Noncontrolling Interests can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shionogi Net Income Including Noncontrolling Interests Chart

Shionogi Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Income Including Noncontrolling Interests
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,134.92 1,030.93 956.67 1,380.29 1,071.80

Shionogi Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Income Including Noncontrolling Interests Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 199.93 298.64 324.56 251.71 227.85

Shionogi Net Income Including Noncontrolling Interests Calculation

Net Income Including Noncontrolling Interests is the net income of the group after the adjustment of all expenses and benefit. It includes the net income (loss) attributable to noncontrolling and redeemable noncontrolling interests and the net income (loss) attributable to the company.

Net Income Including Noncontrolling Interests for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,103 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shionogi Net Income Including Noncontrolling Interests Related Terms

Thank you for viewing the detailed overview of Shionogi's Net Income Including Noncontrolling Interests provided by GuruFocus.com. Please click on the following links to see related term pages.

Shionogi (Shionogi) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shionogi & Co Ltd (OTCPK:SGIOY) » Definitions » Net Income Including Noncontrolling Interests
Comparable Companies
TSE:4523 TSE:4581 TSE:4516 TSE:4530 TSE:4887 TSE:4540 TSE:4506 TSE:4547 TSE:4521 TSE:4534 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA XSWX:SDZ VTRS NBIX SZSE:000538 NSE:DIVISLAB
Traded in Other Exchanges
SGIOF:USA 4507:Japan SH0:Germany
Address
1-8, Doshomachi 3-chome, Chuo-ku, Osaka, JPN, 541-0045
Website
http://www.shionogi.co.jp
Shionogi & Co Ltd is a specialty and generic drug manufacturing company. The company focuses on the manufacturing and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Shionogi engages in manufacturing, formulation, packaging, and analysis as part of its commercialization research that spans late stage drug discovery through commercial production. The company's research and development strategy utilizes partnership and licensing opportunities with academic constituents and venture companies.

Shionogi (Shionogi) Headlines

From GuruFocus

Shionogi & Co Ltd R&D Meeting Transcript

By GuruFocus Research • 02-14-2024

Full Year 2019 Shionogi & Co Ltd Earnings Presentation Transcript

By GuruFocus Research • 02-14-2024

Full Year 2019 Shionogi & Co Ltd Earnings Presentation Transcript

By GuruFocus Research • 02-14-2024

Shionogi & Co Ltd R&D Meeting Transcript

By GuruFocus Research • 02-14-2024